Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2025-12-25 @ 6:57 PM
Study NCT ID:
NCT00288704
Status:
COMPLETED
Last Update Posted:
2011-12-06
First Post:
2006-02-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12
Start Date Type:
None
Primary Completion Date:
2008-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-06
First Submit QC Date:
None
Study First Post Date:
2006-02-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-09-30
Results First Submit QC Date:
None
Results First Post Date:
2009-11-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-12-01
Last Update Post Date:
2011-12-06
Last Update Post Date Type:
ESTIMATED